CMJAX
Price
$41.35
Change
-$0.28 (-0.67%)
Updated
Sep 20 closing price
VIMSX
Price
$71.38
Change
-$0.13 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

CMJAX vs VIMSX

Header iconCMJAX vs VIMSX Comparison
Open Charts CMJAX vs VIMSXBanner chart's image
Calvert US Mid Cap Core Rspnb Idx A
Price$41.35
Change-$0.28 (-0.67%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$71.38
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CMJAX vs VIMSX Comparison Chart
Loading...
VS
CMJAX vs. VIMSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMJAX is a Buy and VIMSX is a Buy.

FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 172B vs. CMJAX (471M). VIMSX pays higher dividends than CMJAX: VIMSX (1.38) vs CMJAX (0.77). CMJAX was incepted earlier than VIMSX: CMJAX (9 years) vs VIMSX (26 years). CMJAX is a more actively managed with annual turnover of: 25.00 vs. VIMSX (13.00). VIMSX has a lower initial minimum investment than CMJAX: VIMSX (3000) vs CMJAX (5000). CMJAX (25.35) and VIMSX (25.11) have marching annual gain over last year. CMJAX (58.08) and VIMSX (56.75) have equivalent 5 years return.
CMJAXVIMSXCMJAX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years26 years-
Gain YTD11.72712.55793%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets471M172B0%
Annual Yield % from dividends0.771.3856%
Returns for 1 year25.3525.11101%
Returns for 3 years7.259.8274%
Returns for 5 years58.0856.75102%
Returns for 10 yearsN/A128.21-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSE10.090.15
+1.51%
Inspired Entertainment
FOUR86.901.01
+1.18%
Shift4 Payments
CALT40.00-0.16
-0.40%
Calliditas Therapeutics AB
BCE35.04-0.15
-0.43%
BCE
ACST2.70-0.08
-2.88%
Acasti Pharma